CellChorus selected as a Defense TechConnect Innovation Challenge company for healthcare
Winners will showcase leading-edge solutions at the Defense TechConnect 2022 Innovation Summit & Expo on September 26-29
PRESS RELEASE
HOUSTON, Texas — August 5, 2022 — CellChorus Inc., the leader in applying artificial intelligence to visually evaluate how thousands of individual cells perform over time, today announced that it has been selected as an Innovation Challenge winner in the healthcare category for the 2022 Defense TechConnect Innovation Summit & Expo.
Entering its tenth year, the annual summit, co-located with the Fall SBIR/STTR Innovation Conference, brings together defense, private industry, federal agency, and academic leadership to accelerate state-of-the-art technology solutions for the military and national security.
CellChorus merges artificial intelligence with a nanowell imaging platform to evaluate thousands of videos of how cells interact over time. Developers and manufacturers of therapies for infectious diseases, cancer, and other therapeutic areas apply the CellChorus Time-lapse Imaging In Nanowell Grids (TIMING™) platform to evaluate interactions between thousands of individual immune cells and target cells to understand which cells perform best and why. Early access customers rely on the platform to evaluate mechanism of action, prioritize candidates for clinical trials, evaluate patient response, and improve process development during manufacturing.
About CellChorus
CellChorus is the leader in applying artificial intelligence to visually evaluate how thousands of individual cells, such as T cells and NK cells, perform over time. The company applies Time-lapse Imaging Microscopy In Nanowell Grids (TIMING™) with neural network-based detection to identify cells and evaluate their activity, including how they move, activate, kill, and survive. The patent-protected CellChorus platform can link TIMING data and insights with information from other analysis modalities such as single-cell RNA sequencing and flow cytometry to provide a comprehensive understanding of cellular function, state and phenotype for the life sciences industry. Please visit cellchorus.com for more information.
Company Contact:
Daniel Meyer
CellChorus Inc.
TIMING@cellchorus.com
SOURCE CellChorus Inc.